Inventor · disambiguated record
Ethan S. Burstein
Also filed as: BURSTEIN ETHAN · BURSTEIN ETHAN S
6 granted patents·16 pending applications·15 citations·filing 2002–2024
74Inventor score
Top patents by PatentIndex Score
22 records- 0184US11345693B2Compounds, salts thereof and methods for treatment of diseasesACADIA PHARM INC·Filed 2020·Granted May 31, 2022·2 cites·38 claims
- 0282US11135211B2Pimavanserin for treating impulse control disorderACADIA PHARM INC·Filed 2018·Granted Oct 5, 2021·5 cites·20 claims
- 0376US7348140B1Clinical indications for genotyping polymorphic variants of G-protein coupled receptorsACADIA PHARM INC·Filed 2002·Granted Mar 25, 2008·8 cites·4 claims
- 0476US2025197385A1Compounds, salts thereof and methods for treatment of diseasesACADIA PHARM INC·Filed 2024·Application pending·0 cites
- 0569US12139477B2Compounds, salts thereof and methods for treatment of diseasesACADIA PHARM INC·Filed 2022·Granted Nov 12, 2024·0 cites·30 claims
- 0654US2005123964A1G-protein coupled receptors high-throughput functional assayFiled 2004·Application pending·0 cites
- 0751US2016263189A1Treatment of a neurodegenerative disease or disorderACADIA PHARM INC·Filed 2014·Application pending·0 cites
- 0850US2008280303A1G-protein coupled receptors high-throughput functional assayBURSTEIN ETHAN S·Filed 2008·Application pending·0 cites
- 0950US2022000852A15-ht2a serotonin receptor inverse agonists or antagonists for use in reducing amyloid-beta peptides and accumulation of amyloid plaquesACADIA PHARM INC·Filed 2021·Application pending·0 cites
- 1048US2009209525A1Enabling methods to identify allosteric modulators of receptor activitySPALDING TRACY A·Filed 2008·Application pending·0 cites
- 1148US2022288048A1Pimavanserin for treating schizophrenia or for treating psychosis secondary to neurodegenerative disorders or depressive disorderACADIA PHARM INC·Filed 2020·Application pending·0 cites
- 1247US2006252744A1Use of N-desmethylclozapine and related compounds as dopamine stabilizing agentsBURSTEIN ETHAN S·Filed 2006·Application pending·0 cites
- 1345US2022016101A1Methods of treating depression, anxiety and sexual dysfunction using the compound pimavanserinACADIA PHARM INC·Filed 2019·Application pending·0 cites
- 1443US2007213359A1Bicyclic-nitrogen compounds as modulators of ghrelin receptor and uses thereofACADIA PHARM INC·Filed 2006·Application pending·0 cites
- 1542US9670209B2Muscarinic agonistsACADIA PHARM INC·Filed 2014·Granted Jun 6, 2017·0 cites·20 claims
- 1642US2013197032A1Phenylpiperidine compounds for the treatment of neurological and psychiatric disordersCARLSSON LIZZIE MARIA·Filed 2011·Application pending·0 cites
- 1738US11440884B2Compounds, salts thereof and methods for treatment of diseasesACADIA PHARM INC·Filed 2018·Granted Sep 13, 2022·0 cites·17 claims
- 1838US2014329903A1Treatment of neurodegenerative diseasesBURSTEIN ETHAN S·Filed 2012·Application pending·0 cites
- 1938US2008318960A1PAR2-modulating compounds and their useBURSTEIN ETHAN·Filed 2006·Application pending·0 cites
- 2038US2011206607A1Imidazol (1,2-a)pyridines and related compounds with activity at cannabinoid cb2 receptorsOLSSON ROGER·Filed 2008·Application pending·0 cites
- 2135US2019117636A15-ht2a serotonin receptor inverse agonists or antagonists for use in reducing amyloid-beta peptides and accumulation of amyloid plaquesACADIA PHARM INC·Filed 2017·Application pending·0 cites
- 2234US2006217370A1Compounds useful for the treatment and prevention of pain and screening methods thereforBURSTEIN ETHAN·Filed 2006·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ethan S. Burstein files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →